🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

CSX To Rally 20%? Here Are 5 Other Price Target Changes For Monday

Published 24/10/2022, 12:14
© Reuters.  CSX To Rally 20%? Here Are 5 Other Price Target Changes For Monday
CSX
-
IXIC
-
TGTB34
-
CSXC34
-

  • Raymond James raised CSX Corporation (NASDAQ: NASDAQ:CSX) price target from $31 to $33. Raymond James analyst Patrick Tyler Brown maintained the stock with an Outperform rating. CSX shares rose 1.7% to close at $27.54 on Friday.
  • Keybanc cut the price target on Match Group (NASDAQ:MTCH), Inc. (NASDAQ: MTCH) from $82 to $74. Keybanc analyst Justin Patterson maintained an Overweight rating on the stock. Match Group shares fell 0.5% to $42.77 in pre-market trading.
  • BMO Capital lowered Green Plains Inc. (NASDAQ: GPRE) price target from $45 to $31. BMO Capital analyst Kenneth Zaslow downgraded the stock from Outperform to Market Perform. Green Plains shares rose 5.2% to close at $29.02 on Friday.
  • Piper Sandler cut NovoCure Limited (NASDAQ: NVCR) price target from $90 to $70. Piper Sandler analyst Jason Bednar downgraded the stock from Overweight to Neutral. NovoCure fell 1.5% to $71.55 in pre-market trading.
  • Barclays (LON:BARC) cut Analog Devices (NASDAQ:ADI), Inc. (NASDAQ: ADI) price target from $180 to $140. Barclays analyst Blayne Curtis downgraded the stock from Overweight to Equal-Weight. Analog Devices shares fell 1.6% to $144.29 in pre-market trading.
  • HC Wainwright & Co cut Talaris Therapeutics, Inc. (NASDAQ: TALS) price target from $18 to $12. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating on the stock. Talaris Therapeutics shares fell 2.8% to $1.38 in pre-market trading.
Check out this: This Analyst With 90% Accuracy Rate Slashes PT On Snap; Here Are 5 Stock Picks For Last Week From Benzinga's Most Accurate Analysts

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.